Author/Creator: Kekow, J - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Kekow, J

1. AB0074 Influence of cobalt and chromium ions on TGF-BETA expression and mineralization of bone forming cells IN-VITRO. (15th June 2017)

Authors:: Drynda, S; Drynda, A; Kekow, J; Lohmann, CH
Journal:: Annals of the rheumatic diseases
Issue:: Volume 76(2017)Supplement 2
Page Start:: 1072
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Canakinumab for first line steroid-free treatment in a child with systemic-onset juvenile idiopathic arthritis. (2nd November 2017)

Authors:: Horneff, G; Peitz, J; Kekow, J; Foell, D
Journal:: Scandinavian journal of rheumatology
Issue:: Volume 46:Number 6(2017)
Page Start:: 500
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Comparative effectiveness of tumour necrosis factor α inhibitors in combination with either methotrexate or leflunomide. Issue 12 (6th January 2009)

Authors:: Strangfeld, A; Hierse, F; Kekow, J; von Hinueber, U; Tony, H-P; Dockhorn, R; Listing, J; Zink, A
Journal:: Annals of the rheumatic diseases
Issue:: Volume 68:Issue 12(2009)
Page Start:: 1856
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Interleukin 10 promoter microsatellite polymorphisms are associated with response to long term treatment with etanercept in patients with rheumatoid arthritis. Issue 4 (2nd September 2004)

Authors:: Schotte, H; Schlüter, B; Drynda, S; Willeke, P; Tidow, N; Assmann, G; Domschke, W; Kekow, J; Gaubitz, M
Journal:: Annals of the rheumatic diseases
Issue:: Volume 64:Issue 4(2005)
Page Start:: 575
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. OP0029 Association of plasma mmp-3 levels and the presence of the shared epitope in patients with rheumatoid arthritis. (1st June 2001)

Authors:: Drynda, S; Kühne, C; Kekow, J
Journal:: Annals of the rheumatic diseases
Issue:: Volume 60(2001)Supplement 1
Page Start:: A364
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. OP0096 Transcriptome analysis in rheumatoid arthritis treated with a tnf neutralising tnf receptor: fusion protein (etanercept). (1st June 2001)

Authors:: Kekow, J; Drynda, S; Koczan, D; Thiesen, HJ
Journal:: Annals of the rheumatic diseases
Issue:: Volume 60(2001)Supplement 1
Page Start:: A44
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial. Issue 01 (16th March 2009)

Authors:: Kekow, J; Moots, R J; Emery, P; Durez, P; Koenig, A; Singh, A; Pedersen, R; Robertson, D; Freundlich, B; Sato, R
Journal:: Annals of the rheumatic diseases
Issue:: Volume 69:Issue 01(2010)
Page Start:: 222
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Soluble tumour necrosis factor receptor treatment does not affect raised transforming growth factor β levels in rheumatoid arthritis. Issue 3 (1st March 2002)

Authors:: Drynda, S; Kühne, C; Kekow, J
Journal:: Annals of the rheumatic diseases
Issue:: Volume 61:Issue 3(2002)
Page Start:: 254
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

9. THU0071 The role of transforming growth factor b (tgfb) in bone metabolism in rheumatoid arthritis. (1st June 2001)

Authors:: Drynda, S; Pap, G; Kühne, C; Neumann, W; Kekow, J
Journal:: Annals of the rheumatic diseases
Issue:: Volume 60(2001)Supplement 1
Page Start:: A365
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10. Treatment continuation in patients receiving biological agents or conventional DMARD therapy. Issue 9 (11th February 2005)

Authors:: Zink, A; Listing, J; Kary, S; Ramlau, P; Stoyanova-Scholz, M; Babinsky, K; von Hinueber, U; Gromnica-Ihle, E; Wassenberg, S; Antoni, C; Herzer, P; Kekow, J; Schneider, M; Rau, R
Journal:: Annals of the rheumatic diseases
Issue:: Volume 64:Issue 9(2005)
Page Start:: 1274
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗